leadf
logo-loader
viewIXICO PLC

IXICO plc - Notice of Results

RNS Number : 5401M
IXICO plc
12 May 2020
 

IXICO plc

("IXICO" or the "Company")

 

Notice of Results

 

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces it will release its interim results for the six months ended 31 March 2020 on Wednesday 20 May 2020.

 

A recording of the results presentation will be made available on the Company's website on the morning here: https://ixico.com/investors/company-information/investor-videos/

 

 

For further information please contact:

 

IXICO plc

+44 (0)20 3763 7498

Giulio Cerroni, Chief Executive Officer

Grant Nash, Chief Financial Officer

 

 

 

Cenkos Securities PLC (Nominated adviser and sole broker)

+44 (0)20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

 

Michael F Johnson / Russell Kerr (Sales)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus / Lianne Cawthorne /

Alice Woodings

Mob: 07980 541 893 / 07584 391 303 /

 07407 804 654

 

 

     

 

About IXICO

IXICO's purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience.

Our goal is to be a leading proponent in the use of AI in clinical development, to improve biopharma R&D productivity through the adoption of breakthrough data analytics in precision healthcare. Through the deployment of novel AI algorithms, we analyse and interpret brain scans and digital biosensor data to enable better trial design, patient selection and ultimately clinical outcomes across all phases of clinical evaluation. Our data analytics services are deployed on some of the most important clinical trials in neuroscience, providing valuable insights to disease progression and patient safety, enabling our clients to make better informed decisions earlier in the clinical development pathway.

More information is available on www.IXICO.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NORBUGDURDBDGGB

Quick facts: IXICO PLC

Price: 83

Market: AIM
Market Cap: £39.09 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

IXICO CEO 'delighted' with stronger than anticipated second half growth

IXICO PLC's (LON:IXI) Giulio Cerroni caught up with Proactive London's Katie Pilbeam after announcing they've raised earnings expectations for the current fiscal year. He says revenues for the year to the end of September 2020 will be in line with, or slightly ahead of, current market...

on 24/8/20